Clair Health: an early-access hormone-aware wearable and app

A wearable health product needs a trust boundary before a hormone claim.

Clair Health describes an early-access wearable and app built around continuous hormone-aware health insights. Its September 20 homepage names training and recovery, fertility planning, hormonal-pattern understanding, and perimenopause support. It also advertises HSA/FSA eligibility and a founding-member offer.

The useful buyer question is not whether a wearable “understands hormones.” It is where readings, predictions, backups, research participation, and health decisions are handled.

Product and user boundary

Clair’s public page describes a multimodal sensor system and models trained against clinical-grade hormone measurements. Those are company claims. They should not be rewritten as a diagnosis, treatment recommendation, or independently validated clinical result.

The privacy policy gives a more concrete architecture claim: biometric readings, cycle information, symptom logs, and predictions are stored locally on the phone; the AI runs locally; optional cloud backup is encrypted; and research participation is opt-in. Those statements describe Clair’s published policy, not an external audit.

The intended user is a person deciding whether the device and app fit a health-tracking goal. A clinician, partner, or employer may be a different reader with different authority. This profile does not collapse those roles.

First evaluation

Before relying on the product, ask what the device measures directly, what the model infers, which states are uncertain or unavailable, where raw readings and predictions are stored, how backup and research participation are enabled, and how a user exports or deletes the record.

Use the company’s published product and privacy claims as an acceptance checklist. This packet contains no device use, clinical validation, or medical outcome measurement.

Price and availability boundary

The homepage labels the product early access and says founding members ship in December 2026. It advertises a limited founding-member offer, but this profile does not treat the offer as a universal price or availability promise. The page also says HSA/FSA eligible; eligibility should be checked with the plan administrator and current terms.

Clair is a useful profile for a buyer comparing wearables because the decision includes local processing, optional backup, research consent, and the difference between a wellness product claim and clinical evidence.

Sources checked — September 20, 2026: Speedrun profile, Clair homepage, and Clair privacy policy.